EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

From Uptake to Therapeutic Function in Engineered Exosome Delivery Systems

Yiwei Li, Limin Jin, Pengli Gao, Mingmei Li, Zengkai Zhao, Jianjun Jiang, Ming An, Fangzhou Li iD

Research · 01.01.2026 · 9

DOI: 10.34133/research.1389 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Research, online erschienen am 12.08.2026. Verfasst von Yiwei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical E…. Die Arbeit nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine, National Natural Science Foundation of China, China Association for Science and Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered exosomes are increasingly recognized as promising vehicles for precision drug delivery. Genetic display, chemical modification, physical loading, and hybrid vesicle construction have expanded their applications, while introducing additional variables to the interpretation of delivery outcomes. Because engineering can alter vesicle properties, receptor engagement, endocytic routing, intracellular trafficking, and functional readouts, tissue accumulation or cellular uptake alone is insufficient to define effective delivery. This review traces engineered exosome delivery from cellular uptake to therapeutic function, covering engineering strategies, targeting validation, endocytic routing, intracellular fate, and functional readouts. We further discuss the strengths and limitations of commonly used evaluation methods. Across biomedical applications, we emphasize that delivery evidence should be judged according to cargo type, site of action, disease model, and therapeutic mechanism. By linking engineering design, assay selection, and evidence strength, this review supports a more careful interpretation of engineered exosome delivery.

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medic…
  • College of Chemistry and Materials Science, Hebei University, Baoding, Hebei Province 071002, PR China.
  • Bao Ding No. 1 Central Hospital, Baoding, Hebei Province 071002, PR China.

ORCID-Profile: Fangzhou Li

Förderung

  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine
  • National Natural Science Foundation of China
  • China Association for Science and Technology
  • Natural Science Foundation of Tianjin Municipality
  • China Postdoctoral Science Foundation
  • Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China

Zitieren

APA

Li, Y., Jin, L., Gao, P., Li, M., Zhao, Z., Jiang, J., An, M., & Li, F. (2026). From Uptake to Therapeutic Function in Engineered Exosome Delivery Systems. Research, 9. https://doi.org/10.34133/research.1389

Vancouver

Li Y, Jin L, Gao P, Li M, Zhao Z, Jiang J, et al. From Uptake to Therapeutic Function in Engineered Exosome Delivery Systems. Research. 2026;9. doi:10.34133/research.1389

BibTeX
@article{Li2026,
  author = {Li, Yiwei and Jin, Limin and Gao, Pengli and Li, Mingmei and Zhao, Zengkai and Jiang, Jianjun and An, Ming and Li, Fangzhou},
  title = {From Uptake to Therapeutic Function in Engineered Exosome Delivery Systems},
  journal = {Research},
  year = {2026},
  volume = {9},
  doi = {10.34133/research.1389}
}
Kostenlos starten →